/ / /
Dave possesses over 20 years of operational and executive management experience in both pharma and biotech. Dave previously served as CEO in the infectious disease business at Roivant Sciences, a biopharmaceutical drug development company, in one of its infectious disease businesses. Prior to his role at Roivant, Dave was Senior Vice President, Commercial, at Novo Nordisk U.S., where he led the successful transformation of the company’s commercial operating model into a purely integrated sales and marketing organization. He led the company through multiple new product launches, including one of the most successful launches in Type 2 diabetes to date.
Dave holds a degree in biology from Towson University, an MBA from Lehigh University and completed the graduate program in population health and healthy policy at Thomas Jefferson University.